A recent study reveals that patients who discontinue blockbuster slimming jabs like Mounjaro or Wegovy can put back on lost weight much more quickly than those who stop conventional diet and exercise programs.
Published data in a major medical journal shows that while obese people frequently drop a large proportion of their total mass while on the medication, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Individuals using such treatments must be aware of the potential of fast weight regain when the treatment concludes," stated lead investigator Dr. Susan Jebb.
Such speed of recovery implies a return to starting mass within about 18 months.
Analyzing Approaches
The study, which looked at dozens of studies involving thousands of participants, contrasted the effects of these new drugs with older methods.
Scientists note that people who shed pounds through diet and exercise typically have a more gradual creep back—perhaps 100 grams monthly—once they finish.
Explaining the Rapid Rebound
Nutrition scientists propose the mechanism of the jabs explains the accelerated rebound.
The injections mimic a natural hormone called GLP-1, which controls hunger.
"Long-term administration of GLP-1 levels far above than normal might result in the body to produce less of its endogenous GLP-1, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' means hunger is unsuppressed, making overeating a significant risk."
A Lifelong Issue?
The NHS suggest the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Professionals argue that, due to the likelihood of weight regain, the treatment is often ongoing.
This opinion is reinforced by drug manufacturers, who note that the results "emphasize the persistent character of obesity," similar to managing diseases like hypertension.
User Accounts
People who have discontinued the medication report a powerful return of hunger.
"It was like a switch flipping and you become extremely hungry," described an individual.
This challenge is compounded if individuals have not established lasting dietary or behavioural changes during therapy.
Widespread Use
Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with interest being substantial.
- Use is greater among women than men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, experts stress that while the jabs are potent tools for shedding pounds, they are not a magic cure and lasting health benefits likely depends on combined behavioural support.
